… Previous studies on inflammatory biomarkers and COPD exacerbations are scarce, but
the studies that have been conducted so far support our findings. A study from the ECLIPSE …

… exacerbation. We hypothesized whether increased serum inflammatory biomarkers are
associated with the clinical outcomes of COPD exacerbation caused by different infectious …

… to date for the diagnosis of COPD and asthma, the aim of the … exacerbation and 6weeks
later at the stable phase, as potential diagnostic biomarkers for asthma and COPD exacerbations…

… inflammatory biomarkers are associated with increased risk of comorbidities in COPD by
examining 8,656 patients with COPD … A COPD exacerbation was defined as hospitalization from …

… in stable and exacerbation phases of COPD patients as … course of these biomarkers after
COPD exacerbation to evaluate … Inflammatory markers that increase in COPD play an important …

… , whereas measurement of inflammatory biomarkers is increasingly implemented in research.
Methodological issues that may influence the measurement of biomarkers, such as sample …

… In this review, we have focused our attention on blood-based biomarkers to diagnose
exacerbations. This type of sample has clear advantages that make clinical translation facile …

… exacerbation, showed that inflammatory biomarkers in sputum, as a group, were increased at
the visit prior to exacerbation. A … not increased until an exacerbation is established. Several …

… The present study is the first to evaluate the time course of recovery in airway and
systemic inflammatory markers at exacerbation of COPD, in a cohort of patients with well-characterised …

… Inflammatory biomarkers increase with exacerbation compared to the remission state, mean
WBC, CRP and fibrinogen at 12.212 × 10 9 /L, 39.462 mg/L and 5.09 g/L in exacerbation …